ÂÜÀòÂÒÂ×

Glenn Walthall is an accomplished business leader and investor with a diverse background in finance and management. Currently serving as Managing Partner at Gaston Capital since January 2015, Glenn focuses on meaningful minority investments in growth companies across the United States. In addition to this role, Glenn holds the position of Chairman of the Board at both Bold Therapeutics Inc. and Intezyne Technologies. Prior experience includes founding Ware River Advisors and serving as Director at Dragonfly Capital Partners, alongside significant roles at Bank of America and Adhesion Wealth Advisor Solutions. Glenn Walthall earned an MBA and a BS in Management Science from Virginia Tech.